Back

News

Category

[Press Release] Accelarated Scientific Advise from European Medicines Adgency EMA for XAV19 Market Authorisation

July 8, 2021. # Download our press release (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

Summer 2021. >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Alert] XENOTHERA signs a pre-order contract of its anti-covid treatment with the French government

May 11, 2021. # Download our press information (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

May 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Alert] XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV19

May 3, 2021. # Download our press information (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

April 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Release] Completion of patients’ enrolment in the POLYCOR clinical trial promoted by the Nantes University Hospital

April 21, 2021. # Download our press release (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

February 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Newsletter] XENONEWS

January 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody

December 2021. # Download our press information (english version) # Télécharger notre...

Read More

[Press Release] XAV19 : validation of the first dose of anti-Covid treatment of XENOTHERA

November 12, 2020. # Download our press release (english version) # Télécharger...

Read More

[Infography/Infographie] Covid19

# 5 KEY POINTS TO KNOW ABOUT ANTIBODIES # Available here #...

Read More

[Newsletter- 9] NEWS/INFOS

September 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

Read More

[Press Alert] XENOTHERA obtains authorization from ANSM to start the clinical trial of XAV19, its anti Covid treatment

August 10, 2020. # Download our press release (english version) # Télécharger...

Read More

[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.

July 15, 2020. # Download our press release (english version) # Télécharger...

Read More

[Newsletter - 8] NEWS/INFOS

July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

Read More

[Newsletter - 7] NEWS/INFOS

June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Alerte actualité] Financement XENOTHERA

15 Juin 2020. Download the press release /Télécharger le communiqué

Read More

[Newsletter-6] NEWS/INFO

June 15, 2020. >> Breaking news / Edition spéciale << Download our...

Read More

[Newsletter-5] NEWS/INFOS

May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

In the News/ A la une

Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...

Read More

[Newsletter -4] NEWS/INFOS

May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Newsletter -3] NEWS/INFOS

May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Infographie] Traitement XAV19

Available here/Disponible ici

Read More

XENOTHERA

21 rue La Nouë de Fer, 44200 Nantes, France

contact@xenothera.com

Media : xenothera@akkanto.fr
Linkedin-in